Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 159

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 159
---
  As opposed to the NYSE American Section 704, which mandates that a listed company hold its annual shareholders                   
 meeting within one year of the company’s fiscal year-end, we are required, under the Companies Law, to hold an annual shareholders         
 meeting each calendar year and within 15 months of the last annual shareholders meeting.                                                   |
| ● | Distribution of periodic                                                                                                                   
 reports to shareholders; proxy solicitation. As opposed to the NYSE American rules, which require listed issuers to make                   
 such reports available to shareholders in one of a number of specific manners, Israeli law does not require us to distribute periodic      
 reports directly to shareholders, and the generally accepted business practice in Israel is not to distribute such reports to shareholders 
 but to make such reports available through a public website. In addition to making such reports available on a public website, we          
 currently make our audited consolidated financial statements available to our shareholders at our offices and will only mail such          
 reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC’s proxy solicitation               
 rules.                                                                                                                                     |

Foreign Private Issuer

Under
the Companies Law, companies incorporated under the laws of the State of Israel whose shares are publicly traded, including companies
with shares listed on the NYSE American, are considered public companies under Israeli law and are required to comply with various corporate
governance requirements under Israeli law relating to matters such as external directors, the audit committee, the compensation committee
and an internal auditor. This is the case even if our shares are not listed on a stock exchange in Israel. These requirements are in
addition to the corporate governance requirements imposed by the Listing Rules of the NYSE American, and other applicable provisions
of U.S. securities laws to which we are subject (as a foreign private issuer).

Board Practices

Introduction

Our
amended and restated articles of association to be in effect upon completion of this offering provide that we may have between five (5)
and eight (8) directors, including directors who serve as external directors under the Companies Law. Immediately as of the effective
time of the registration statement to which this prospectus relates, our board of directors will consist of five (5) directors. Other
than our external directors (if any), our directors are elected by an ordinary resolution at an annual general meeting of our shareholders.
Our directors are divided into three classes (as nearly equal in number as practicable), class I, class II and class III, that are each
e